by Shelley Ross | May 19, 2022 | Press Releases
Full sponsorship of the phase II trial of UC-MS infusions to treat severe lung damage in COVID-19 ARDS has been successfully transferred to a corporate entity which will soon begin a large randomized double-blind multi-site trial. The initial research for the...
by Admin | Jan 5, 2021 | Press Releases
Full sponsorship of the phase III trial of UC-MSC infusions to treat severe lung damage in COVID-19 ARDS has been successfully transferred to a corporate entity which will soon begin a large randomized double-blind multi-site trial. The initial research for the...
by Shelley Ross | May 7, 2020 | Press Releases
FOR IMMEDIATE RELEASE: Miami, Fla. (May 6, 2020) – The Diabetes Research Institute Foundation (DRIF) today announced a donation of $3 million from North America’s Building Trades Unions (NABTU), to support the clinical trial of umbilical cord mesenchymal stem cells...
by Shelley Ross | May 5, 2020 | Latest News, Press Releases
FOR IMMEDIATE RELEASE May 5, 2020: The Cure Alliance announces the start of planning for phase II of the clinical trial of umbilical cord-derived mesenchymal stem cells (UC-MSCs) to block the life-threatening lung inflammation that accompanies severe cases of...
by Shelley Ross | Apr 9, 2020 | Press Releases
FOR IMMEDIATE RELEASE: APRIL 9, 2020 After a lightning round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of...
by Admin | Apr 8, 2015 | Press Releases
UCLA’S CHARLES BRUNICARDI , M.D., JOINS THE BOARDGLOBAL SCIENTISTS OFFICIALLY LAUNCH NON-PROFIT (April 8, 2015 Miami, FL.) Former executive producer of ABC’s Good Morning America, Shelley Ross, has been named president of The Cure Alliance it was announced...
